CN101250233A - Extraction method of safflower mulberry parasitic polysaccharide - Google Patents
Extraction method of safflower mulberry parasitic polysaccharide Download PDFInfo
- Publication number
- CN101250233A CN101250233A CNA2008100708166A CN200810070816A CN101250233A CN 101250233 A CN101250233 A CN 101250233A CN A2008100708166 A CNA2008100708166 A CN A2008100708166A CN 200810070816 A CN200810070816 A CN 200810070816A CN 101250233 A CN101250233 A CN 101250233A
- Authority
- CN
- China
- Prior art keywords
- safflower
- polysaccharide
- mulberry
- polysaccharides
- dialysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 60
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 59
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 59
- 244000020518 Carthamus tinctorius Species 0.000 title claims abstract description 38
- 235000003255 Carthamus tinctorius Nutrition 0.000 title claims abstract description 38
- 240000000249 Morus alba Species 0.000 title abstract description 33
- 235000008708 Morus alba Nutrition 0.000 title abstract description 33
- 238000000605 extraction Methods 0.000 title abstract description 8
- 230000003071 parasitic effect Effects 0.000 title description 8
- 239000000284 extract Substances 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000002904 solvent Substances 0.000 claims abstract description 12
- 239000006228 supernatant Substances 0.000 claims abstract description 7
- 238000003809 water extraction Methods 0.000 claims abstract description 4
- 238000000502 dialysis Methods 0.000 claims description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 229960004756 ethanol Drugs 0.000 claims description 12
- 240000001638 Scurrula parasitica Species 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 20
- 241000699670 Mus sp. Species 0.000 abstract description 14
- 108090000623 proteins and genes Proteins 0.000 abstract description 11
- 102000004169 proteins and genes Human genes 0.000 abstract description 11
- 241000196324 Embryophyta Species 0.000 abstract description 10
- 239000007788 liquid Substances 0.000 abstract description 6
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 5
- 206010039491 Sarcoma Diseases 0.000 abstract description 5
- 206010003445 Ascites Diseases 0.000 abstract description 4
- 238000006911 enzymatic reaction Methods 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 201000007270 liver cancer Diseases 0.000 abstract description 2
- 208000014018 liver neoplasm Diseases 0.000 abstract description 2
- 230000001875 tumorinhibitory effect Effects 0.000 abstract description 2
- 230000000259 anti-tumor effect Effects 0.000 description 19
- 208000001088 cerebrotendinous xanthomatosis Diseases 0.000 description 12
- 238000002512 chemotherapy Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000000967 suction filtration Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000001376 precipitating effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical group ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 4
- 235000014066 European mistletoe Nutrition 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 4
- 241000221012 Viscum Species 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 229920001491 Lentinan Polymers 0.000 description 3
- 229960004397 cyclophosphamide Drugs 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 229940115286 lentinan Drugs 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940044683 chemotherapy drug Drugs 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- FAWLNURBQMTKEB-URDPEVQOSA-N 213546-53-3 Chemical compound N([C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N1[C@@H](CCC1)C(O)=O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C FAWLNURBQMTKEB-URDPEVQOSA-N 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000008877 Isorel M Substances 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000316341 Taxillus chinensis Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000017128 negative regulation of NF-kappaB transcription factor activity Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 108010045913 viscum album peptide Proteins 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种植物多糖的提取方法,具体地说,涉及一种红花桑寄生多糖的提取方法。为实现本发明目的采用的技术方案是:将红花桑寄生枝叶粉碎后,用乙醇提取后过滤取滤渣,滤渣用热水浸提,经去蛋白和小分子成分后得到红花桑寄生多糖,其特征是经热水浸提法提取后的上清液,首先采用sevage法、TCA法、酶法或者这三种方法联用去除蛋白,再透析去除小分子成分。采用本发明所述的多糖提取方法,只需使用一次沉淀剂来沉淀多糖,节省了大量溶剂;同时提高了多糖的得率和水溶性。所得到红花桑寄生多糖提取物,对小鼠肉瘤S180有较好的抑制效果,并可显著延长荷肝癌腹水瘤H22小鼠的寿命,其抑瘤效果没有剂量依赖性。The invention relates to a method for extracting plant polysaccharides, in particular to a method for extracting polysaccharides from safflower mulberry. The technical scheme adopted for realizing the purpose of the present invention is: after the safflower mulberry branches and leaves are pulverized, the filter residue is filtered after extraction with ethanol, the filter residue is extracted with hot water, and the safflower mulberry polysaccharide is obtained after removing protein and small molecular components. It is characterized in that the supernatant liquid extracted by the hot water extraction method first adopts sevage method, TCA method, enzymatic method or the combination of these three methods to remove protein, and then dialyzes to remove small molecular components. By adopting the polysaccharide extraction method of the present invention, only one precipitant is used to precipitate the polysaccharide, which saves a lot of solvents; meanwhile, the yield and water solubility of the polysaccharide are improved. The obtained safflower mulberry polysaccharide extract has a good inhibitory effect on mouse sarcoma S180, and can significantly prolong the lifespan of H22 mice bearing liver cancer ascites tumor, and its tumor inhibitory effect has no dose-dependence.
Description
技术领域 technical field
本发明涉及一种植物多糖的提取方法,具体地说,涉及一种红花桑寄生(Scurrula parasitica L.)多糖的提取方法。The invention relates to a method for extracting plant polysaccharides, in particular to a method for extracting polysaccharides from Scurrula parasitica L.
背景技术 Background technique
红花桑寄生Scurrula parasitica L.是桑寄生科桑寄生亚科梨果寄生属半寄生性植物,为我国特有的植物,主要分布于我国广东、广西、云南及福建等南方地区。传统上红花桑寄生常作为桑寄生Taxillus chinensis(DC.)Danser的代用品入药,具补肝肾、祛风湿、降血压、安血养胎等功效,主治风湿、关节痛、高血压、坐骨神经痛、腰痛、产后乳少等症。The safflower mulberry Scurrula parasitica L. is a semi-parasitic plant of the genus Pyroparasitica of the subfamily Morusaceae. It is a unique plant in my country and is mainly distributed in southern regions such as Guangdong, Guangxi, Yunnan and Fujian. Traditionally, safflower mulberry is often used as a substitute for mulberry tree Taxillus chinensis (DC.) Danser. It has the functions of nourishing liver and kidney, dispelling rheumatism, lowering blood pressure, calming blood and nourishing fetus, etc. It is mainly used for rheumatism, joint pain, high blood pressure, sciatic nerve Pain, low back pain, postpartum milk loss embolism.
桑寄生科植物一般含大量的黄酮类成分,我们在前期的研究中发现红花桑寄生总黄酮提取物对急性髓系白血病有较好的抑瘤效果,并可增敏临床重要抗肿瘤化疗药物多柔比星的疗效,机制研究表明其可能是一种良好的NF-κB抑制剂。然而,尚未见对红花桑寄生多糖及其功用的研究。Plants of the family Morushiaceae generally contain a large amount of flavonoids. In our previous research, we found that the total flavonoids extract of Safflower mulberry has good anti-tumor effect on acute myeloid leukemia, and can sensitize important clinical anti-tumor chemotherapy drugs Efficacy of doxorubicin, mechanism studies show that it may be a good NF-κB inhibitor. However, there is no research on the parasitic polysaccharides of safflower mulberry and their functions.
植物多糖具有多方面的生物活性,能够调节机体免疫机能,具有抗病毒、抗菌、抗寄生虫、抗肿瘤、抗辐射、抗衰老等功能,因而越来越受重视。近年来,大量的研究表明,中药多糖具有抗肿瘤作用,且毒副作用小,因而越来越成为抗肿瘤研究的热点。香菇多糖、当归多糖、猪苓多糖、云芝多糖等一批质量稳定、疗效确切、毒性和不良反应小的多糖类药物已作为抗肿瘤药物广泛用于临床。Plant polysaccharides have various biological activities, can regulate the immune function of the body, and have anti-virus, anti-bacterial, anti-parasitic, anti-tumor, anti-radiation, anti-aging and other functions, so they are getting more and more attention. In recent years, a large number of studies have shown that polysaccharides of traditional Chinese medicine have anti-tumor effects, and have less toxic and side effects, so it has become a hot spot in anti-tumor research. Lentinan, angelica polysaccharide, polyporus polysaccharide, versicolor polysaccharide and other polysaccharide drugs with stable quality, definite curative effect, little toxicity and adverse reactions have been widely used in clinic as anti-tumor drugs.
红花桑寄生的同科植物槲寄生在国外是一种研究较多的具有抗肿瘤作用的植物,在欧洲,自1920年就对槲寄生的抗肿瘤作用开始研究,其提取物具有多种抗癌效果,对乳腺癌、胃癌与结肠癌等常见肿瘤有一定治疗作用。英国和澳大利亚已分别开发出商品名为Iscador和Isorel的槲寄生标准植物提取物用于癌症的临床治疗。已有的研究表明槲寄生提取物中的有效抗肿瘤成分可能主要是多糖、凝集素、毒肽、生物碱以及多酚类物质。Mistletoe, the same family plant of Safflower mulberry, is a kind of plant with anti-tumor effect that has been studied abroad. In Europe, the anti-tumor effect of mistletoe has been studied since 1920. Its extract has a variety of anti-tumor effects. It has a certain therapeutic effect on common tumors such as breast cancer, gastric cancer and colon cancer. The standard plant extracts of mistletoe with trade names Iscador and Isorel have been developed in the UK and Australia respectively for clinical treatment of cancer. Existing studies have shown that the effective anti-tumor components in mistletoe extracts may mainly be polysaccharides, lectins, toxic peptides, alkaloids and polyphenols.
植物多糖的提取过程大多采用传统的先沉淀再去蛋白的方法。我们在研究中发现采用传统的方法来提取红花桑寄生多糖,需多次使用沉淀剂从溶液中沉淀多糖,耗费大量的溶剂,且得率低,提取出的多醣类物质水溶性很差,不利于应用。本发明采用先去蛋白再沉淀多糖的提取方法,则只需使用一次沉淀剂来沉淀多糖,节省了大量溶剂;得率高,同时提高了多糖的水溶性,便于药物研究和实际应用。The extraction process of plant polysaccharides mostly adopts the traditional method of first precipitation and then protein removal. In our research, we found that using the traditional method to extract polysaccharides from the safflower mulberry parasite requires multiple use of precipitating agents to precipitate polysaccharides from the solution, which consumes a large amount of solvent and has a low yield. The extracted polysaccharides have poor water solubility. Not conducive to application. The present invention adopts the extraction method of firstly removing protein and then precipitating polysaccharide, and only needs to use a precipitant once to precipitate polysaccharide, which saves a large amount of solvent; the yield is high, and the water solubility of polysaccharide is improved at the same time, which is convenient for drug research and practical application.
发明内容 Contents of the invention
本发明的目的在于提供一种先去蛋白再沉淀多糖的红花桑寄生多糖的提取方法。The object of the present invention is to provide a method for extracting the parasitic polysaccharide of safflower mulberry by first removing the protein and then precipitating the polysaccharide.
为实现本发明的目的采用的技术方案是:将红花桑寄生枝叶粉碎后,用乙醇回流提取,过滤取滤渣,滤渣用热水浸提,经沉淀、干燥后得到红花桑寄生多糖提取物,其特征是经热水浸提法提取后的上清液,首先采用sevage法、TCA法或酶法,或者是他们之间的任意两种方法,或者是三种方法联用去除蛋白,再使用透析袋进行透析除去小分子成分。The technical scheme adopted for realizing the purpose of the present invention is: after the safflower mulberry branches and leaves are crushed, they are extracted with ethanol under reflux, filtered to get the filter residue, the filter residue is extracted with hot water, and the safflower mulberry polysaccharide extract is obtained after precipitation and drying , which is characterized in that the supernatant extracted by the hot water extraction method first adopts the sevage method, the TCA method or the enzyme method, or any two methods between them, or a combination of the three methods to remove the protein, and then Dialysis is performed using a dialysis bag to remove small molecule components.
采用本发明所述的红花桑寄生多糖提取方法,只需使用一次沉淀剂来沉淀多糖,节省了大量溶剂;提高了多糖的得率,同时提高了多糖的水溶性,便于药物研究和实际应用。所得到红花桑寄生多糖提取物,对小鼠肉瘤S180有较好的抑制效果,并与临床重要抗肿瘤化疗药物有显著的协同效果;该提取物也可显著延长荷肝癌腹水瘤H22小鼠的寿命。研究表明该提取物的抑瘤效果并没有剂量依赖性,而是有一最佳剂量,过高或过低的剂量均使得抑瘤效果下降。By adopting the method for extracting polysaccharides from safflower mulberry parasites of the present invention, only one precipitant is needed to precipitate polysaccharides, which saves a large amount of solvents; the yield of polysaccharides is improved, and the water solubility of polysaccharides is improved at the same time, which is convenient for drug research and practical application . The obtained safflower mulberry polysaccharide extract has a good inhibitory effect on mouse sarcoma S180, and has a significant synergistic effect with clinically important anti-tumor chemotherapy drugs; lifespan. Studies have shown that the anti-tumor effect of the extract is not dose-dependent, but there is an optimal dose, too high or too low a dose will reduce the anti-tumor effect.
具体的提取方法包括以下步骤:The specific extraction method comprises the following steps:
(1)采集红花桑寄生嫩枝和叶,水洗、晾干、60℃烘干,粉碎机成粉末;(1) Collect safflower mulberry parasitic twigs and leaves, wash with water, dry in the air, dry at 60°C, and pulverize into powder;
(2)取粉末,加入乙醇回流提取,以去除其中的脂溶性成分,过滤取滤渣,挥干溶剂;(2) Take the powder, add ethanol to reflux extraction, to remove the fat-soluble components therein, filter to take the filter residue, and evaporate the solvent;
(3)取挥干溶剂后的滤渣,进行热水浸泡提取,滤渣∶水=1∶5~15,热水温度为80~95℃浸泡提取,2小时后离心或抽滤去渣;取上清液,并于60℃下减压浓缩处理;(3) Take the filter residue after evaporating the solvent, carry out hot water soaking and extraction, filter residue: water=1:5~15, the temperature of hot water is 80~95 ℃ soaking and extracting, after 2 hours, centrifuge or suction filter to remove the residue; take the above The clear liquid was concentrated under reduced pressure at 60°C;
(4)重复步骤(3)三遍;合并3次上清液。(4) Repeat step (3) three times; combine the supernatants for 3 times.
(5)采用sevage法、TCA法、酶法或者这几种方法联用,重复三次,将上清液中的蛋白去除;(5) Using the sevage method, TCA method, enzymatic method or a combination of these methods, repeat three times to remove the protein in the supernatant;
(6)去蛋白后的上清液装入透析袋进行透析,流水透析2天,蒸馏水透析1天,去除小分子成分,得到多糖溶液;(6) Put the deproteinized supernatant into a dialysis bag for dialysis, dialysis with running water for 2 days, and dialysis with distilled water for 1 day to remove small molecular components and obtain a polysaccharide solution;
(7)在多糖溶液中加入沉淀剂,在低温下沉淀多糖,使沉淀剂在溶液中的浓度为65%~85%(v/v),离心收集沉淀,该沉淀物经醇类、酮类和乙醚依次洗涤后冷冻干燥即得本发明所说的红花桑寄生多糖。(7) Add a precipitating agent to the polysaccharide solution, and precipitate the polysaccharide at low temperature so that the concentration of the precipitating agent in the solution is 65% to 85% (v/v). Washing with diethyl ether in sequence and then freeze-drying can obtain the safflower mulberry polysaccharide of the present invention.
本发明所述的透析袋进行透析时,流水透析2天,蒸馏水透析1天;所说的透析袋的透析分子量为7000~14000D。When the dialysis bag of the present invention is used for dialysis, 2 days of running water dialysis and 1 day of distilled water dialysis; the dialysis molecular weight of the dialysis bag is 7000-14000D.
本发明所述的沉淀剂,是指含有1~4个碳链的醇类溶剂,最优选的是乙醇。The precipitant in the present invention refers to an alcoholic solvent containing 1 to 4 carbon chains, most preferably ethanol.
本发明所述的洗涤步骤中采用的洗涤剂依次为无水乙醇、丙酮和乙醚洗涤。The washing agent adopted in the washing step of the present invention is dehydrated alcohol, acetone and ether washing successively.
具体实施方式 Detailed ways
以下实施例用于对本发明作进一步阐述,但并不因此而限制本发明的范围。The following examples are used to further illustrate the present invention, but do not limit the scope of the present invention thereby.
实施例1:Example 1:
取粉碎好的药材粉末180g,加入80%乙醇回流提取3次,每次2h,抽滤取滤渣,挥干溶剂后加水按料液比1∶10,95℃热水中提取,每次2h,共提取3次,合并3次提取液,抽滤去渣,滤液于60℃下减压浓缩至约1000ml体积,加入1/3体积的sevage(氯仿∶正丁醇=4∶1),振荡20min后,8000rpm离心15min,去除蛋白沉淀,取上清重复多次直到无蛋白为止。将去蛋白后的溶液装入透析袋透析,流水透析2天,蒸馏水透析1天。减压浓缩至1/2体积,加入3倍量95%乙醇,于冰箱中静置24h进行沉淀,离心收集沉淀,依次用无水乙醇、丙酮、乙醚洗涤,再经冷冻真空干燥得红花桑寄生多糖提取物3.67g。Take 180g of crushed medicinal material powder, add 80% ethanol to reflux and extract for 3 times, each time for 2 hours, take the filter residue by suction filtration, evaporate the solvent, add water according to the ratio of material to liquid 1:10, extract in hot water at 95°C, each time for 2 hours, Extracted 3 times in total, combined the 3 extracts, filtered to remove the residue, concentrated the filtrate under reduced pressure at 60°C to a volume of about 1000ml, added 1/3 volume of sevage (chloroform:n-butanol=4:1), and oscillated for 20min Afterwards, centrifuge at 8000rpm for 15min to remove the protein precipitate, take the supernatant and repeat it several times until there is no protein. The deproteinized solution was put into a dialysis bag for dialysis, running water dialysis for 2 days, distilled water dialysis for 1 day. Concentrate under reduced pressure to 1/2 volume, add 3 times the amount of 95% ethanol, let it stand in the refrigerator for 24 hours to precipitate, centrifuge to collect the precipitate, wash with absolute ethanol, acetone, ether in turn, and then freeze and vacuum-dry to obtain safflower mulberry Parasitic polysaccharide extract 3.67g.
实施例2:Example 2:
取粉碎好的药材粉末180g,加入80%乙醇回流提取3次,每次2h,抽滤取滤渣,挥干溶剂后加水按料液比1∶10,95℃热水中提取,每次2h,提取3次,合并3次提取液,抽滤去渣,滤液加入0.5%木瓜蛋白酶(w/v),40℃酶解5h后,加热到100℃10min灭酶活,于60℃下减压浓缩至约1000ml体积,加入1/3体积的sevage(氯仿∶正丁醇=4∶1),振荡20min后,8000rpm离心15min,重复3次。将去蛋白后的溶液装入透析袋透析,流水透析2天,蒸馏水透析1天。浓缩至1/2体积,加入3倍量95%乙醇,于冰箱中静置24h进行沉淀,离心收集沉淀,依次用无水乙醇、丙酮、乙醚洗涤,再经冷冻真空干燥得红花桑寄生多糖提取物4.87g。Take 180g of crushed medicinal material powder, add 80% ethanol to reflux and extract for 3 times, each time for 2 hours, take the filter residue by suction filtration, evaporate the solvent, add water according to the ratio of material to liquid 1:10, extract in hot water at 95°C, each time for 2 hours, Extract 3 times, combine 3 extracts, remove residue by suction filtration, add 0.5% papain (w/v) to the filtrate, enzymatically hydrolyze at 40°C for 5h, heat to 100°C for 10min to inactivate enzyme activity, concentrate under reduced pressure at 60°C To about 1000ml volume, add 1/3 volume of sevage (chloroform:n-butanol=4:1), shake for 20min, centrifuge at 8000rpm for 15min, repeat 3 times. The deproteinized solution was put into a dialysis bag for dialysis, running water dialysis for 2 days, distilled water dialysis for 1 day. Concentrate to 1/2 volume, add 3 times the amount of 95% ethanol, put it in the refrigerator for 24 hours to precipitate, centrifuge to collect the precipitate, wash with absolute ethanol, acetone, ether in turn, and then freeze and vacuum dry to obtain the parasitic polysaccharide of Safflower mulberry Extract 4.87g.
实施例3:Example 3:
取粉碎好的药材粉末180g,加入80%乙醇回流提取3次,每次2h,抽滤取滤渣,挥干溶剂后加水按料液比1∶10,95℃热水中提取,每次2h,共提取3次,合并3次提取液,抽滤去渣,滤液于60℃下减压浓缩至约1000ml体积,加入等体积30%三氯乙酸,振荡20min后,4℃下静置2h,8000rpm离心15min,去除蛋白沉淀。将去蛋白后的溶液装入透析袋透析,流水透析2天,蒸馏水透析1天。浓缩至1/2体积,加入3倍量95%乙醇,于冰箱中静置24h进行沉淀,离心收集沉淀,依次用无水乙醇、丙酮、乙醚洗涤,再经冷冻真空干燥得红花桑寄生多糖提取物3.42g。Take 180g of crushed medicinal material powder, add 80% ethanol to reflux and extract for 3 times, each time for 2 hours, take the filter residue by suction filtration, evaporate the solvent, add water according to the ratio of material to liquid 1:10, extract in hot water at 95°C, each time for 2 hours, Extracted 3 times in total, combined 3 extracts, filtered to remove residue, concentrated the filtrate under reduced pressure at 60°C to a volume of about 1000ml, added an equal volume of 30% trichloroacetic acid, oscillated for 20min, then stood at 4°C for 2h, 8000rpm Centrifuge for 15 minutes to remove protein precipitates. The deproteinized solution was put into a dialysis bag for dialysis, running water dialysis for 2 days, distilled water dialysis for 1 day. Concentrate to 1/2 volume, add 3 times the amount of 95% ethanol, put it in the refrigerator for 24 hours to precipitate, centrifuge to collect the precipitate, wash with absolute ethanol, acetone, ether in turn, and then freeze and vacuum dry to obtain the parasitic polysaccharide of Safflower mulberry Extract 3.42g.
实施例4:Example 4:
取粉碎好的药材粉末180g,加入80%乙醇回流提取3次,每次2h,抽滤取滤渣,挥干溶剂后加水按料液比1∶10,95℃热水中提取,每次2h,提取3次,合并3次提取液,抽滤去渣,滤液加入0.2%木瓜蛋白酶(w/v),60℃酶解2h后,加热到100℃10min灭酶活,于60℃下减压浓缩至约1000ml体积,加入等体积30%三氯乙酸,振荡20min后,4℃下静置2h,8000rpm离心15min,去除蛋白沉淀。将去蛋白后的溶液装入透析袋透析,流水透析2天,蒸馏水透析1天。浓缩至1/2体积,加入3倍量95%乙醇,于冰箱中静置24h进行沉淀,离心收集沉淀,依次用无水乙醇、丙酮、乙醚洗涤,再经冷冻真空干燥得红花桑寄生多糖提取物4.32g。Take 180g of crushed medicinal material powder, add 80% ethanol to reflux and extract for 3 times, each time for 2 hours, take the filter residue by suction filtration, evaporate the solvent, add water according to the ratio of material to liquid 1:10, extract in hot water at 95°C, each time for 2 hours, Extract 3 times, combine 3 extracts, remove residue by suction filtration, add 0.2% papain (w/v) to the filtrate, enzymatically hydrolyze at 60°C for 2h, heat to 100°C for 10min to inactivate enzyme activity, and concentrate under reduced pressure at 60°C To a volume of about 1000ml, add an equal volume of 30% trichloroacetic acid, shake for 20min, let stand at 4°C for 2h, and centrifuge at 8000rpm for 15min to remove protein precipitates. The deproteinized solution was put into a dialysis bag for dialysis, running water dialysis for 2 days, distilled water dialysis for 1 day. Concentrate to 1/2 volume, add 3 times the amount of 95% ethanol, put it in the refrigerator for 24 hours to precipitate, centrifuge to collect the precipitate, wash with absolute ethanol, acetone, ether in turn, and then freeze and vacuum dry to obtain the parasitic polysaccharide of Safflower mulberry Extract 4.32g.
实施例5:Example 5:
按实施例4所述方法提取的红花桑寄生多糖提取物(以下简称SPS)腹腔注射对小鼠肉瘤S180的抑制作用。Inhibition of sarcoma S180 in mice by intraperitoneal injection of the safflower mulberry polysaccharide extract extracted according to the method described in Example 4 (hereinafter referred to as SPS).
昆明种小鼠50只(雌雄各半,体重18±2g,由福建医科大学实验动物中心提供),S180腹水瘤株由福建医科大学药学院提供。取腹腔内传代7d的S180肉瘤小鼠,脱臼处死,在无菌条件下抽取腹腔内瘤细胞,并以生理盐水洗涤3次,2500rpm离心3min,用灭菌生理盐水调整瘤细胞浓度为5×106/ml,接种于小鼠右腋皮下,每只小鼠接种0.2ml。50 Kunming mice (half male and half female, weighing 18±2 g, provided by the Experimental Animal Center of Fujian Medical University), and the S180 ascites tumor strain was provided by the School of Pharmacy, Fujian Medical University. S180 sarcoma mice passaged in the abdominal cavity for 7 days were taken and killed by dislocation. The intraperitoneal tumor cells were extracted under aseptic conditions, washed three times with normal saline, centrifuged at 2500 rpm for 3 min, and the concentration of tumor cells was adjusted to 5×10 with sterile normal saline. 6 /ml, inoculated subcutaneously in the right armpit of mice, each mouse was inoculated with 0.2ml.
于接种24h后随机分组,每组10只,分成生理盐水组、环磷酰胺组(CTX,20mg/kg.d)、SPS低剂量组(50mg/kg.d)、SPS中剂量组(100mg/kg.d)、SPS高剂量组(150mg/kg.d)。以上各组均每天腹腔注射给药0.01ml/g,连续给药10天,末次给药24h后,脱臼处死荷瘤小鼠,取肿瘤组织、脾脏、胸腺,去血污称重,计算抑瘤率、脾指数(mg脾重/10g体重)和胸腺指数(mg胸腺重/10g体重)。结果见表1。24 hours after inoculation, they were randomly divided into groups, 10 in each group, and divided into normal saline group, cyclophosphamide group (CTX, 20mg/kg.d), SPS low-dose group (50mg/kg.d), SPS middle-dose group (100mg/kg.d). kg.d), SPS high dose group (150mg/kg.d). Each of the above groups was intraperitoneally administered 0.01ml/g per day for 10 consecutive days. 24 hours after the last administration, the tumor-bearing mice were killed by dislocation, and the tumor tissues, spleen, and thymus were removed and weighed to calculate the tumor inhibition rate. , spleen index (mg spleen weight/10g body weight) and thymus index (mg thymus weight/10g body weight). The results are shown in Table 1.
抑瘤率(%)=(对照组平均瘤重-实验组平均瘤重)/对照组平均瘤重×100%Tumor inhibition rate (%)=(average tumor weight in control group-average tumor weight in experimental group)/average tumor weight in control group×100%
表1红花桑寄生多糖对S180荷瘤小鼠的抗肿瘤作用(n=10)Table 1 Anti-tumor effect of safflower mulberry polysaccharides on S180 tumor-bearing mice ( n=10)
与对照组比较:*P<0.01,**P<0.001Compared with the control group: *P<0.01, **P<0.001
由表1可看出,三种剂量的红花桑寄生多糖提取物对小鼠S180均有较好的抑瘤效果,与生理盐水组比较,差异显著,抑瘤效果以100mg/kg.d的剂量最好,过高剂量反而导致抑瘤效果下降,这与文献中报道的植物多糖的免疫调节作用大多有最适剂量相符。三个剂量的SPS组与生理盐水组相比均能增加小鼠脾重量,只有SPS100mg/kg.d组差异显著(P<0.001),红花桑寄生多糖对胸腺重量的增加影响不大,而阳性对照药CTX极显著地降低了脾指数和胸腺指数。It can be seen from Table 1 that three doses of polysaccharide extracts of safflower mulberry parasites have good tumor inhibitory effects on mice S180. Compared with the normal saline group, the difference is significant. The dose is the best, but too high a dose will lead to a decrease in the anti-tumor effect, which is consistent with most of the immunomodulatory effects of plant polysaccharides reported in the literature. Three doses of SPS groups can increase the mouse spleen weight compared with the normal saline group, only the SPS100mg/kg.d group has a significant difference (P<0.001). Positive control drug CTX significantly reduced spleen index and thymus index.
实施例6Example 6
按实施例4所述方法提取的红花桑寄生多糖提取物对环磷酰胺(CTX)的增效作用。The synergistic effect of the safflower mulberry polysaccharide extract extracted by the method described in Example 4 on cyclophosphamide (CTX).
材料及接种方法同实施例5,于接种24h随机分组给药,分成生理盐水组、CTX低剂量组(10mg/kg.d)、CTX中剂量组(20mg/kg.d)、CTX高剂量组(30mg/kg.d)、SPS(100mg/kg.d)+CTX低剂量组(10mg/kg.d)、SPS(100mg/kg.d)+CTX中剂量组(20mg/kg.d)、SPS(100mg/kg.d)+CTX高剂量组(30mg/kg.d),以上各组均每天ip给药0.01ml/g,连续给药10d,末次给药后24h脱臼处死荷瘤小鼠,取瘤称质量,计算抑瘤率。比较单纯用CTX治疗组与加用多糖组间抑瘤率的差异,结果见表2。The materials and inoculation method are the same as those in Example 5, administered in random groups 24 hours after inoculation, and divided into normal saline group, CTX low-dose group (10mg/kg.d), CTX middle-dose group (20mg/kg.d), CTX high-dose group (30mg/kg.d), SPS (100mg/kg.d) + CTX low dose group (10mg/kg.d), SPS (100mg/kg.d) + CTX medium dose group (20mg/kg.d), SPS (100mg/kg.d)+CTX high-dose group (30mg/kg.d), the above groups were administered 0.01ml/g ip every day for 10 days, and the tumor-bearing mice were killed by dislocation 24 hours after the last administration , Take the tumor and weigh it, and calculate the tumor inhibition rate. The difference in tumor inhibition rate between the CTX treatment group alone and the polysaccharide group was compared, and the results are shown in Table 2.
表2红花桑寄生多糖对CTX的增效作用(n=10)Table 2 The synergistic effect of safflower mulberry polysaccharides on CTX ( n=10)
与生理盐水组比较:*P<0.001;Compared with normal saline group: *P<0.001;
与CTX比较:△P<0.05;△△P<0.01Compared with CTX: △ P<0.05; △△ P<0.01
由表2可看出,红花桑寄生多糖提取物显著地增强了环磷酰胺的抑瘤效果。It can be seen from Table 2 that the polysaccharide extract of Safflower mulberry significantly enhanced the antitumor effect of cyclophosphamide.
实施例7Example 7
按实施例2所述方法提取的红花桑寄生多糖提取物显著延长了荷H22肝癌腹水瘤小鼠的寿命。The polysaccharide extract extracted according to the method described in Example 2 significantly prolongs the lifespan of mice bearing H22 liver cancer ascites tumor.
材料及来源同实施例5。无菌条件下抽取小鼠腹腔内传代7d的H22腹水细胞,计数后用生理盐水稀释,每只小鼠腹腔接种5×106个细胞,次日开始尾静脉注射给药,连续7天。停止给药后计算小鼠生存天数。阴性对照药为生理盐水,阳性对照药为环磷酰胺,SPS分为高、中、低三个剂量组,结果见表3。Material and source are with embodiment 5. The H22 ascites cells passaged in the peritoneal cavity of mice for 7 days were extracted under sterile conditions, counted and diluted with normal saline, and 5×10 6 cells were inoculated in the peritoneal cavity of each mouse, and administered by tail vein injection from the next day for 7 consecutive days. The survival days of the mice were counted after the administration was stopped. The negative control drug was normal saline, the positive control drug was cyclophosphamide, and SPS was divided into high, medium and low dose groups. The results are shown in Table 3.
生命延长率的计算公式为:The formula for calculating life extension rate is:
生命延长率=(给药组平均存活天数-对照组平均存活天数)/对照组平均存活天数×100%Life extension rate=(average survival days of drug administration group-average survival days of control group)/average survival days of control group×100%
表3红花桑寄生多糖对S180荷瘤小鼠的抗肿瘤作用(n=10)Table 3 Anti-tumor effect of safflower mulberry polysaccharides on S180 tumor-bearing mice ( n=10)
与对照组比较:*P<0.01Compared with the control group: *P<0.01
从表3可看出,红花桑寄生多糖提取物显著地延长了荷瘤小鼠的生命,与对肉瘤S180的抑制结果相似,中剂量组100mg/kg.d这一剂量对荷H22肝癌腹水瘤的小鼠延寿效果最好,表明红花桑寄生多糖提取物的抗肿瘤效果有一最佳剂量,而不呈线性的量效关系。这一点与香菇多糖的抗肿瘤效应相似,表明红花桑寄生多糖提取物可能与香菇多糖有相似的抗肿瘤作用机制。As can be seen from Table 3, the polysaccharide extract of safflower mulberry parasite significantly prolongs the life of tumor-bearing mice, which is similar to the inhibition result of sarcoma S180. The dose of 100mg/kg. The effect of prolonging life in mice with tumor is the best, indicating that the anti-tumor effect of safflower mulberry polysaccharide extract has an optimal dose, and there is no linear dose-effect relationship. This point is similar to the anti-tumor effect of lentinan, indicating that the polysaccharide extract of safflower mulberry polysaccharide may have a similar anti-tumor mechanism with lentinan.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100708166A CN101250233B (en) | 2008-03-27 | 2008-03-27 | Medicinal application of polysaccharide extract from Safflower mulberry |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100708166A CN101250233B (en) | 2008-03-27 | 2008-03-27 | Medicinal application of polysaccharide extract from Safflower mulberry |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101250233A true CN101250233A (en) | 2008-08-27 |
CN101250233B CN101250233B (en) | 2010-06-02 |
Family
ID=39953850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100708166A Expired - Fee Related CN101250233B (en) | 2008-03-27 | 2008-03-27 | Medicinal application of polysaccharide extract from Safflower mulberry |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101250233B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102626460A (en) * | 2011-05-19 | 2012-08-08 | 兰州理工大学 | Preparation method of Zanthoxylum dissitum Hemsl skin polysaccharide and application |
CN104288171A (en) * | 2014-09-19 | 2015-01-21 | 罗颂平 | Application of parasitic loranthus total polysaccharides in preparation of antiabortifacient |
CN108530550A (en) * | 2018-04-23 | 2018-09-14 | 湘潭大学 | A kind of oil tea loranthus parasiticus polysaccharides and its extracting method inhibiting blood clotting |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100586443C (en) * | 2006-07-28 | 2010-02-03 | 福建医科大学附属协和医院 | Application of a kind of safflower mulberry parasite extract |
-
2008
- 2008-03-27 CN CN2008100708166A patent/CN101250233B/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102626460A (en) * | 2011-05-19 | 2012-08-08 | 兰州理工大学 | Preparation method of Zanthoxylum dissitum Hemsl skin polysaccharide and application |
CN104288171A (en) * | 2014-09-19 | 2015-01-21 | 罗颂平 | Application of parasitic loranthus total polysaccharides in preparation of antiabortifacient |
CN104288171B (en) * | 2014-09-19 | 2017-06-13 | 罗颂平 | Application of the Ramulus Taxilli total starches in antiabortive medicine is prepared |
CN108530550A (en) * | 2018-04-23 | 2018-09-14 | 湘潭大学 | A kind of oil tea loranthus parasiticus polysaccharides and its extracting method inhibiting blood clotting |
Also Published As
Publication number | Publication date |
---|---|
CN101250233B (en) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109276576A (en) | The use of white meat Ganoderma lucidum polysaccharide in the preparation of antitumor drugs | |
CN100497395C (en) | Use of argyi leaf polysaccharide extract | |
CN105017438B (en) | A kind of Radix et Rhizoma Gynurae divaricatae polysaccharide and its application in preparing for immunological regulation and anti-tumor drug and functional food | |
CN115521385B (en) | A polysaccharide from Leuvia mycelium and its preparation method and application in anti-tumor | |
CN105175569B (en) | The method that camellia chrysantha polysaccharide is extracted from golden camellia tea | |
CN101250233B (en) | Medicinal application of polysaccharide extract from Safflower mulberry | |
CN110105461A (en) | A kind of adjunct antineoplastic compound sea lettuce extract and its technology of preparing | |
CN104042623A (en) | Application of rhizopus nigricans exopolysaccharides in preparation of medicine for treating or preventing gastrointestinal tumors | |
CN110041441B (en) | Safflower polysaccharide, preparation method thereof and application thereof in antitumor drugs | |
CN103610699B (en) | Extraction method of land slug and anti-lung cancer application of land slug | |
CN105175570B (en) | The method that polysaccharide is extracted from golden camellia tea | |
CN106177187B (en) | Tea polyphenol tea polysaccharide composition with synergistic, detoxifying and anti-cancer effects | |
CN105153324B (en) | The extracting method of camellia chrysantha polysaccharide | |
CN105661491B (en) | Peach gum health product and preparation method and application thereof | |
CN116515009B (en) | Dictyophora indusiata egg polysaccharide, extraction method and application thereof in pancreatic cancer resistance | |
CN110585232A (en) | Application of hericium erinaceus polysaccharide in preparation of product for preventing and treating colon cancer | |
CN110664946A (en) | A kind of Ulva polysaccharide composition with antitumor activity and preparation method thereof | |
CN108904521B (en) | A kind of antitumor drug containing Baiwei ginseng polysaccharide and using method thereof | |
CN105147863B (en) | A kind of extraction method and application of Wuzi Yanzong formula total polysaccharide | |
CN101041686A (en) | Wood frog anticancer peptide and preparation method thereof | |
CN102579476B (en) | A kind of antineoplastic vascular suppository containing Radix Asparagi deproteinization polysaccharide and preparation method thereof | |
CN102688475B (en) | A kind of extraction method of gecko anticancer extract | |
CN1969956A (en) | Extract of Kadsura longepedunculata Finet et Gagnep, preparation process and use thereof | |
CN1425691A (en) | Acetyl mannan and its preparing method and use | |
CN104490975B (en) | A kind of preparation method of anti-cancer polysaccharide composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100602 Termination date: 20140327 |